These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 34547092)

  • 1. Most Fully Vaccinated Patients With Cancer Have SARS-CoV-2 Antibodies.
    Slomski A
    JAMA; 2021 Sep; 326(9):800. PubMed ID: 34547092
    [No Abstract]   [Full Text] [Related]  

  • 2. Study Suggests Lasting Immunity After COVID-19, With a Big Boost From Vaccination.
    Abbasi J
    JAMA; 2021 Aug; 326(5):376-377. PubMed ID: 34259836
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
    Anichini G; Terrosi C; Gandolfo C; Gori Savellini G; Fabrizi S; Miceli GB; Cusi MG
    N Engl J Med; 2021 Jul; 385(1):90-92. PubMed ID: 33852796
    [No Abstract]   [Full Text] [Related]  

  • 4. The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity.
    Abbasi J
    JAMA; 2021 Nov; 326(18):1781-1782. PubMed ID: 34673883
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
    Abbasi J
    JAMA; 2021 Sep; 326(10):901. PubMed ID: 34519816
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine.
    Cancer Discov; 2021 Sep; 11(9):2122. PubMed ID: 34272229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    Bradley T; Grundberg E; Selvarangan R; LeMaster C; Fraley E; Banerjee D; Belden B; Louiselle D; Nolte N; Biswell R; Pastinen T; Myers A; Schuster J
    N Engl J Med; 2021 May; 384(20):1959-1961. PubMed ID: 33755375
    [No Abstract]   [Full Text] [Related]  

  • 8. Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    Normark J; Vikström L; Gwon YD; Persson IL; Edin A; Björsell T; Dernstedt A; Christ W; Tevell S; Evander M; Klingström J; Ahlm C; Forsell M
    N Engl J Med; 2021 Sep; 385(11):1049-1051. PubMed ID: 34260850
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 vaccination: the VOICE for patients with cancer.
    van der Veldt AAM; Oosting SF; Dingemans AC; Fehrmann RSN; GeurtsvanKessel C; Jalving M; Rimmelzwaan GF; Kvistborg P; Blank CU; Smit EF; Lemmens VEEP; Hiltermann TJN; Koopmans MPG; Huckriede ALW; Rots NY; van Els CACM; van Baarle D; Haanen JBAG; de Vries EGE
    Nat Med; 2021 Apr; 27(4):568-569. PubMed ID: 33589821
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
    Fendler A; Shepherd STC; Au L; Wilkinson KA; Wu M; Schmitt AM; Tippu Z; Farag S; Rogiers A; Harvey R; Carlyle E; Edmonds K; Del Rosario L; Lingard K; Mangwende M; Holt L; Ahmod H; Korteweg J; Foley T; Barber T; Emslie-Henry A; Caulfield-Lynch N; Byrne F; Shum B; Gerard CL; Deng D; Kjaer S; Song OR; Queval C; Kavanagh C; Wall EC; Carr EJ; Namjou S; Caidan S; Gavrielides M; MacRae JI; Kelly G; Peat K; Kelly D; Murra A; Kelly K; O'Flaherty M; Shea RL; Gardner G; Murray D; Yousaf N; Jhanji S; Van As N; Young K; Furness AJS; Pickering L; Beale R; Swanton C; ; Gandhi S; Gamblin S; Bauer DLV; Kassiotis G; Howell M; Nicholson E; Walker S; Wilkinson RJ; Larkin J; Turajlic S;
    Cancer Cell; 2022 Feb; 40(2):114-116. PubMed ID: 34968417
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients.
    Boyarsky BJ; Chiang TP; Teles AT; Greenberg RS; Krach MR; Ou MT; Massie AB; Tobian AAR; Garonzik-Wang JM; Segev DL; Werbel AWA
    Transplantation; 2021 Oct; 105(10):e137-e138. PubMed ID: 34241987
    [No Abstract]   [Full Text] [Related]  

  • 14. A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation.
    Jeong H; Choi YM; Seo H; Kim BJ
    Front Immunol; 2021; 12():637654. PubMed ID: 33732258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
    He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J
    Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
    Kamar N; Abravanel F; Marion O; Couat C; Izopet J; Del Bello A
    N Engl J Med; 2021 Aug; 385(7):661-662. PubMed ID: 34161700
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistent Immunogenicity of the mRNA COVID-19 Vaccine in Patients Vaccinated Before Kidney Transplant.
    Yi SG; Eagar T; Moore L; Huang HJ; Ibrahim H; Hobeika MJ; McMillan R; Podder H; Ghobrial RM; Gaber AO; Knight RJ
    Transplantation; 2021 Oct; 105(10):e133-e134. PubMed ID: 34155187
    [No Abstract]   [Full Text] [Related]  

  • 18. Trying to Block SARS-CoV-2 Transmission With Intranasal Vaccines.
    Rubin R
    JAMA; 2021 Nov; 326(17):1661-1663. PubMed ID: 34647956
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
    Werbel WA; Boyarsky BJ; Ou MT; Massie AB; Tobian AAR; Garonzik-Wang JM; Segev DL
    Ann Intern Med; 2021 Sep; 174(9):1330-1332. PubMed ID: 34125572
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.
    Marion O; Del Bello A; Abravanel F; Couat C; Faguer S; Esposito L; Hebral AL; Izopet J; Kamar N
    Ann Intern Med; 2021 Sep; 174(9):1336-1338. PubMed ID: 34029487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.